Mark Flower

Newsmax reaches $67M settlement with Dominion Voting Systems in defamation case The voting system manufacturer claimed the news channel made false statements about the company.

Newsmax reaches $67M settlement with Dominion Voting Systems in defamation case.

My family got these payments when my dad died at 34 years old after serving in the Navy for a decade from what he had paid in. I was five. Jeanine is an incurious ignoramus. Thanks @jessicatarlov.bsky.social for correcting her, which is God’s work.

Today is a good day.

Slot explains message Salah new contract sends to Liverpool transfer targets Arne Slot reacts to the news that Mohamed Salah has signed a new two-year deal at Liverpool

#LFC and Mo - another 2 years!

Demand for torpedo bats is booming for batmakers After the new design erupted into the public's attention last weekend, there was an instant surge of interest. “There are 1,500 preorders for a bat that doesn’t exist," one exec said.

At least stock in one company is up (just kidding they’re privately owned). #torpedobats

EchoBack CAR T-cells could be a game changer in cancer immunotherapy Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring.

Really early research in mice but still an interesting approach to #CARTcell therapy in #solidtumors

Indeed a very bad day.
#cellandgenetherapy #CGT

Breaking: FDA's Peter Marks resigns, saying he won't accept Kennedy's 'misinformation and lies' FDA's Peter Marks resigns amid clash with HHS Secretary Robert F. Kennedy over vaccine safety, after being given choice to resign or be fired.

Bad news for many in #CGT endpts.com/fdas-peter-m...

Beneficial genetic changes observed in regular blood donors Researchers at the Francis Crick Institute have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells.

Researchers from the Crick, @dkfz.bsky.social and the German Red Cross Blood Donation Centre have found beneficial genetic changes that arise in the blood stem cells of people who regularly donate blood cells.

www.crick.ac.uk/news-and-fea...

While Liverpool are leading this tie coming into tonight, they’re going to have to play infinitely better than the first leg if they are to stand a chance of getting through. But this is Anfield, surely they will.

USDA cancels $1B in local food purchasing for schools, food banks States have been notified that they will not receive 2025 funding for schools to buy food from nearby farms.

Wrecking ball. www.politico.com/news/2025/03...

I maxed out my credit card, emptied my savings account, and took out a loan to move from Alabama to Bethesda, MD. I don’t even qualify for unemployment since I’ve only worked at NIH for a month. I will be financially and medically devastated.

Seeking suggestions for anywhere that’s hiring!!

My top CGT storylines from 2024 can be read here:

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy - Journal of Translational Medicine In the past decades, Chimeric Antigen Receptor (CAR)-T cell therapy has achieved remarkable success, leading to the approval of six therapeutic products for haematological malignancies. Recently, the ...

New article provides a fantastic overview of next-gen #InVivo #CARTcellTherapies, delivery systems, mfg process, possible drawbacks, and a future that might include #CARNK and #CARM. #CellandGeneTherapy #CARTcells #CellTherapyManufacturing

translational-medicine.biomedcentral.com/articles/10....

Mesoblast Wins First Mesenchymal Stromal Cell Therapy FDA Approval for GVHD The approval concludes what has been a difficult regulatory path for Ryoncil, which suffered FDA rejections in 2020 and 2023.

Is Ryoncil the last #CGT product to gain FDA approval in 2024 or is there one more surprise to come? www.biospace.com/fda/mesoblas...

At @science.org, the Breakthrough of the Year 2024
Lenacapavir – a new injectable drug that prevents HIV infection
"The Long Shot"
science.org/doi/10.1126/...

Can a KETO diet boost CAR T cell function and improve outcomes? #ASH24 #celltherapy

ashpublications.org/ashnewsdaily...

Fred Hutch at #ASH24: Hematologist-oncologist Dr. Natalie Wuliji presents findings from a multi-center study showing how socioeconomic status affects access to allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia #AML. ash.confex.com/ash/2024/web...

The meeting looks set to include the largest Bluesky HCP social media community for any medical congress yet!

👉 Follow the ASH Annual Meeting feed: bsky.app/profile/did:...

CAR T Cells and T-Cell Therapies for Cancer This review summarizes evidence regarding cellular immunotherapies for cancer.

Well written article worth reading… addresses and summarizes challenges in a handy table. jamanetwork.com/journals/jam...

I think we’re leaving X because the platform is so toxic Fab…

Liverpool vs Man City LIVE - score, goals and commentary stream Live coverage of Liverpool vs Manchester City in the Premier League from Anfield

Full-time and #LFC are deserved winners over #MCFC. Gakpo and Salah with the goals. Liverpool nine points clear at the top now, 11 ahead of City #LIVMCI 👇🔴

www.liverpoolecho.co.uk/sport/footba...

Liverpool, Liverpool top of the league, Liverpool top of the league 🎶

Cervical cancer mortality in US women younger than 25 years significantly declined between 2016 and 2021, likely due to the widespread adoption of HPV vaccination.

ja.ma/4i9ghPC

Just going to leave this here…

UP THE REDS ✊🔴 #UCL

"Liverpool, Liverpool top of the league" ringing out around Anfield. Don't usually hear that one on European nights.

CAR T for Lupus Takes Center Stage at ACR 2024 Investigational CAR T therapies stole the spotlight at the American College of Rheumatology Convergence as data presented by Bristol Myers Squibb, Kyverna Therapeutics and more highlighted their poten...

Investigational #CARTtherapies stole the spotlight at the American College of Rheumatology Convergence. Kyverna Therapeutics, Bristol Myers Squibb, Cabaletta Bio, and Fate Therapeutics Inc. all presented data. #lupus #autoimmune #celltherapy #patientaccess www.biospace.com/drug-develop...

Welcome newcomers to the friendly skies of @bsky.app, emerging as the science sharing platform for the future!

Kate and Kite? That’s not going to be confusing at all.